Exponent, Inc. (NASDAQ:EXPO) Shares Sold by Atria Investments Inc

Atria Investments Inc cut its holdings in shares of Exponent, Inc. (NASDAQ:EXPO) by 4.4% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 24,832 shares of the business services provider’s stock after selling 1,131 shares during the quarter. Atria Investments Inc’s holdings in Exponent were worth $2,863,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Quarry LP acquired a new stake in shares of Exponent in the second quarter valued at $25,000. GAMMA Investing LLC raised its position in Exponent by 67.7% in the 2nd quarter. GAMMA Investing LLC now owns 379 shares of the business services provider’s stock valued at $36,000 after purchasing an additional 153 shares in the last quarter. Whittier Trust Co. of Nevada Inc. boosted its stake in shares of Exponent by 166.5% in the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 517 shares of the business services provider’s stock valued at $49,000 after buying an additional 323 shares during the period. USA Financial Formulas acquired a new position in shares of Exponent during the third quarter worth about $60,000. Finally, Benjamin F. Edwards & Company Inc. increased its stake in shares of Exponent by 70.5% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 873 shares of the business services provider’s stock worth $83,000 after buying an additional 361 shares during the period. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Insider Activity at Exponent

In other Exponent news, Director Carol Lindstrom sold 1,039 shares of Exponent stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $96.32, for a total transaction of $100,076.48. Following the transaction, the director now owns 5,871 shares of the company’s stock, valued at $565,494.72. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other Exponent news, Director Carol Lindstrom sold 1,039 shares of Exponent stock in a transaction on Monday, November 4th. The shares were sold at an average price of $96.32, for a total value of $100,076.48. Following the transaction, the director now directly owns 5,871 shares in the company, valued at approximately $565,494.72. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Paul R. Johnston sold 7,000 shares of the company’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $103.83, for a total transaction of $726,810.00. Following the completion of the sale, the director now directly owns 80,742 shares of the company’s stock, valued at $8,383,441.86. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 22,039 shares of company stock valued at $2,291,286 in the last three months. 2.10% of the stock is currently owned by company insiders.

Exponent Trading Down 0.4 %

Shares of Exponent stock opened at $102.56 on Thursday. The company has a fifty day simple moving average of $107.46 and a 200-day simple moving average of $101.96. The stock has a market cap of $5.21 billion, a price-to-earnings ratio of 49.55 and a beta of 0.69. Exponent, Inc. has a 12-month low of $68.70 and a 12-month high of $115.75.

Exponent Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Friday, December 6th will be issued a $0.28 dividend. This represents a $1.12 annualized dividend and a dividend yield of 1.09%. The ex-dividend date is Friday, December 6th. Exponent’s payout ratio is currently 54.11%.

Analysts Set New Price Targets

Separately, Truist Financial reiterated a “buy” rating and set a $120.00 target price (up previously from $100.00) on shares of Exponent in a research note on Friday, July 26th.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.